Following the recommendation, InflaRx intends to halt further development of vilobelimab for the PG indication. The company ...

A systematic review of 63 cases finds that pyoderma gangrenosum in pregnancy is frequently misdiagnosed.

Prof. Niels C. Riedemann, Chief Executive Officer and Founder of InflaRx, said: "We would like to thank the dedicated physicians and pyoderma gangrenosum patients for their participation in this ...

JENA, Germany, May 28, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that ...

There have been some reports of the occurrence of pyoderma gangrenosum in Africa, and in Nigeria, but only one specifically reported pyoderma gangrenosum in association with ulcerative colitis. We ...

A case of a patient with a rare combination of myelofibrosis (MF) and pyoderma gangrenosum was recently published.

Pyoderma gangrenosum (PG), a rare inflammatory skin disease, had been challenging to diagnose due to its nonspecific histological characteristics. Researchers conducted a retrospective study to ...

Summary A nursery epidemic of staphylococcal pyoderma, including 3 cases of Ritter's disease, associated with the appearance of a new strain of staphylococcus, phage Type 3B/71, is described.

Peristomal Pyoderma Gangrenosum (PPG) is a subtype of pyoderma gangrenosum, arising around the stoma after surgical placement of an ileostomy or colostomy in patients with inflammatory bowel diseases.

In this Grand Round, we present a dramatic case of cutaneous sporotrichosis initially presented with an atypical large ulcer without associated lymphocutaneous spread, clinically mimicking pyoderma ...

A 2-point improvement in pain based on a numeric rating scale may indicate that patients are responding to treatment for pyoderma gangrenosum. To help determine whether a patient with pyoderma ...